Protect Pharmaceutical Corp (PRTT) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

Protect Pharmaceutical Corp

CIK: 1493526 Ticker: PRTT
Document and Entity Information
6 Months Ended
Jun. 30, 2018
Document And Entity Information 
Entity Central Index Key0001493526
Document Type10-Q
Document Period End DateJun. 30, 2018
Amendment Flagfalse
Current Fiscal Year End Date--12-31
Entity Filer CategoryNon-accelerated Filer
Entity Small Business flagtrue
Entity Emerging Growth Companyfalse
Entity Ex Transition Periodfalse
Entity Common Stock, Shares Outstanding1,111,460
Trading SymbolPRTT
Document Fiscal Period FocusQ2
Document Fiscal Year Focus2018

View differences made from one quarter to another to evaluate Protect Pharmaceutical Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Protect Pharmaceutical Corp.


Assess how Protect Pharmaceutical Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Protect Pharmaceutical Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors